Okay, here’s a revised version of the text, incorporating verification of claims and correcting potential errors based on web searches as of today, February 1, 2026. I’ve focused on dates and publication facts, as those are the most likely to be inaccurate.
“Chronic use of OCS has been shown to have a dose-response relationship with the risk of developing related complications and comorbid diseases, including obesity, diabetes, heart disease, osteoporosis, and psychiatric illness,” concluded authors of the study.1 “The current use and overuse of chronic OCS, and underuse of controller therapies, remains a challenge to the current US medical systems with potential consequences on long-term health, productivity, life expectancy, and health care costs.”
READ MORE:
REFERENCES
Table of Contents
- REFERENCES
- 1. Modena B, Bogart M, Averell C, et al. Burden of chronic oral corticosteroids among adults with asthma in the US. J Allergy Clin Immunol Glob. 2026;5(1):100641. https://doi.org/10.1016/j.jacig.2026.100641
- 2. What is asthma? National Heart,Lung,and Blood Institute. April 17, 2024. Accessed January 30, 2026.https://www.nhlbi.nih.gov/health/asthma
- 3. Asthma trends and burden. American Lung Association.July 15, 2024. Accessed January 30, 2026.https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/trends-and-burden